192 related articles for article (PubMed ID: 35441343)
1. Hyperlipidemia patients carrying LDLR splicing mutation c.1187-2A>G respond favorably to rosuvastatin and PCSK9 inhibitor evolocumab.
Zhang X; Liu Q; Zhang H; Tan C; Zhu Q; Chen S; Du Y; Yang H; Li Q; Xu C; Wu C; Wang QK
Mol Genet Genomics; 2022 May; 297(3):833-841. PubMed ID: 35441343
[TBL] [Abstract][Full Text] [Related]
2. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
[TBL] [Abstract][Full Text] [Related]
3. Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation.
Shirahama R; Ono T; Nagamatsu S; Sueta D; Takashio S; Chitose T; Fujisue K; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Hokimoto S; Hori M; Harada-Shiba M; Kajiwara I; Ogawa H; Tsujita K
Intern Med; 2018; 57(24):3551-3557. PubMed ID: 30555118
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
5. Efficacy evaluation of PCSK9 monoclonal antibody (Evolocumab) in combination with Rosuvastatin and Ezetimibe on cholesterol levels in patients with coronary heart disease (CHD): A retrospective analysis from a single center in China.
Liu Y; Han B
Transpl Immunol; 2022 Apr; 71():101444. PubMed ID: 34375677
[TBL] [Abstract][Full Text] [Related]
6. The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia.
Hu H; Chen R; Hu Y; Wang J; Lin S; Chen X
Lipids Health Dis; 2021 Sep; 20(1):101. PubMed ID: 34511120
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.
Pisciotta L; Priore Oliva C; Cefalù AB; Noto D; Bellocchio A; Fresa R; Cantafora A; Patel D; Averna M; Tarugi P; Calandra S; Bertolini S
Atherosclerosis; 2006 Jun; 186(2):433-40. PubMed ID: 16183066
[TBL] [Abstract][Full Text] [Related]
8. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W
Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441
[TBL] [Abstract][Full Text] [Related]
9. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor.
Pussadhamma B; Wongvipaporn C; Wutthimanop A; Nuinoon M; Porntadavity S; Jeenduang N
Sci Rep; 2024 Mar; 14(1):6785. PubMed ID: 38514665
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
[TBL] [Abstract][Full Text] [Related]
12. Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.
Pisciotta L; Fasano T; Bellocchio A; Bocchi L; Sallo R; Fresa R; Colangeli I; Cantafora A; Calandra S; Bertolini S
Atherosclerosis; 2007 Oct; 194(2):e116-22. PubMed ID: 17140581
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
14. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
16. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
[TBL] [Abstract][Full Text] [Related]
17. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
18. The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia.
Michikura M; Hori M; Ogura M; Hosoda K; Harada-Shiba M
Atherosclerosis; 2022 Oct; 358():41-46. PubMed ID: 36087353
[TBL] [Abstract][Full Text] [Related]
19. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
20. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.
Ruel I; Aljenedil S; Sadri I; de Varennes É; Hegele RA; Couture P; Bergeron J; Wanneh E; Baass A; Dufour R; Gaudet D; Brisson D; Brunham LR; Francis GA; Cermakova L; Brophy JM; Ryomoto A; Mancini GBJ; Genest J
Clin Chem; 2018 Feb; 64(2):355-362. PubMed ID: 29038147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]